Standard-dose non-sedating second-generation H1-antihistamines (sgAHs) are recommended as first-line therapy in all types of urticaria.

Yet greater awareness of sleep deprivation’s consequences hasn’t translated into a better-rested populace. Data from the CDC ...

A decade has passed since Bobbi Kristina's death, a tragedy sadly similar to her mother Whitney Houston's passing, leaving us ...

Benadryl has been associated with worse school performance and, in one small study, impaired people’s ability to drive more ...

Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...

A new paper argues that the popular allergy medication is a worse choice than newer drugs, like Claritin and Allegra. Experts ...

A study from a University of Oregon researcher and published in the Journal of Applied Physiology, finds that antihistamines ...

A massive global study has ranked the best and safest treatments for chronic hives when antihistamines fall short. The ...

The Global Keratoconjunctivitis Market, valued at approximately USD 472.46 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.31% during the forecast period from 2024 ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...